JP2013523844A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523844A5 JP2013523844A5 JP2013504064A JP2013504064A JP2013523844A5 JP 2013523844 A5 JP2013523844 A5 JP 2013523844A5 JP 2013504064 A JP2013504064 A JP 2013504064A JP 2013504064 A JP2013504064 A JP 2013504064A JP 2013523844 A5 JP2013523844 A5 JP 2013523844A5
- Authority
- JP
- Japan
- Prior art keywords
- ethoxy
- pharmaceutical composition
- asthma
- medicament
- copd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 239000003814 drug Substances 0.000 claims 14
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 12
- 208000006673 asthma Diseases 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- 208000015181 infectious disease Diseases 0.000 claims 8
- 208000024891 symptom Diseases 0.000 claims 8
- DKSVBVKHUICELN-UHFFFAOYSA-N 3-ethoxy-6-[2-[1-(6-methylpyridazin-3-yl)piperidin-4-yl]ethoxy]-1,2-benzoxazole Chemical compound C=1C=C2C(OCC)=NOC2=CC=1OCCC(CC1)CCN1C1=CC=C(C)N=N1 DKSVBVKHUICELN-UHFFFAOYSA-N 0.000 claims 7
- -1 6-methyl-pyridazin-3-yl Chemical group 0.000 claims 4
- 208000037874 Asthma exacerbation Diseases 0.000 claims 4
- 230000006866 deterioration Effects 0.000 claims 4
- 239000007787 solid Substances 0.000 claims 4
- 239000002775 capsule Substances 0.000 claims 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000000890 drug combination Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 210000003928 nasal cavity Anatomy 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2010901601 | 2010-04-15 | ||
| AU2010901601A AU2010901601A0 (en) | 2010-04-15 | Compound for the treatment of respiratory condition or disease | |
| PCT/AU2011/000434 WO2011127538A1 (en) | 2010-04-15 | 2011-04-14 | Compound for treatment of respiratory condition or disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523844A JP2013523844A (ja) | 2013-06-17 |
| JP2013523844A5 true JP2013523844A5 (cg-RX-API-DMAC7.html) | 2014-05-29 |
| JP6148618B2 JP6148618B2 (ja) | 2017-06-14 |
Family
ID=44788654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013504064A Active JP6148618B2 (ja) | 2010-04-15 | 2011-04-14 | 呼吸器の病態又は疾患の治療のための化合物 |
Country Status (16)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110172055B (zh) | 2013-04-12 | 2021-10-29 | 瓦伦塔有限责任公司 | 戊二酰亚胺衍生物、其用途、基于所述衍生物的药物组合物及戊二酰亚胺衍生物的制备方法 |
| AU2015276857B2 (en) * | 2014-06-20 | 2017-10-19 | Vaxart, Inc. | Anhydrous crystalline free base form of-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole |
| WO2024192149A2 (en) * | 2023-03-13 | 2024-09-19 | Altesa BioSciences, Inc. | Method of treating enterovirus in chronic obstructive pulmonary disease patients |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR213700A0 (en) * | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| US20060167109A1 (en) * | 2002-02-14 | 2006-07-27 | Pevear Daniel C | Methods of reducing rhinovirus contagion and related compositions |
| WO2004073710A1 (en) * | 2003-02-21 | 2004-09-02 | Apodemus Ab | Treatment of diseases caused by ljungan virus by using pleconaril |
| US9308199B2 (en) * | 2004-04-29 | 2016-04-12 | Honeywell International Inc. | Medicament formulations |
| WO2006029182A2 (en) * | 2004-09-07 | 2006-03-16 | The La Jolla Institute For Molecular Medicine | Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases |
| AR057623A1 (es) * | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
| EA020455B1 (ru) * | 2008-05-27 | 2014-11-28 | Байота Сайентифик Менеджмент Пти Лтд. | Бис(дигидрофосфатная) соль 6-{2-[1-(6-метил-3-пиридазинил)-4-пиперидинил]этокси}-3-этокси-1,2-бензизоксазола (1:2), способ ее получения и ее применение в композиции и способе лечения или предотвращения пикорнавирусных инфекций |
| TW201016215A (en) * | 2008-07-17 | 2010-05-01 | Schering Corp | Compositions and uses of antiviral active pharmaceutical agents |
-
2011
- 2011-04-14 BR BR112012026244A patent/BR112012026244A2/pt not_active IP Right Cessation
- 2011-04-14 AU AU2011241478A patent/AU2011241478B2/en not_active Ceased
- 2011-04-14 EA EA201201416A patent/EA025224B1/ru not_active IP Right Cessation
- 2011-04-14 CA CA2796207A patent/CA2796207A1/en not_active Abandoned
- 2011-04-14 WO PCT/AU2011/000434 patent/WO2011127538A1/en not_active Ceased
- 2011-04-14 NZ NZ60304011A patent/NZ603040A/en not_active IP Right Cessation
- 2011-04-14 SG SG10201502391WA patent/SG10201502391WA/en unknown
- 2011-04-14 EP EP11768285.6A patent/EP2558097B1/en not_active Not-in-force
- 2011-04-14 JP JP2013504064A patent/JP6148618B2/ja active Active
- 2011-04-14 ES ES11768285.6T patent/ES2647223T3/es active Active
- 2011-04-14 KR KR1020127029232A patent/KR20130106267A/ko not_active Ceased
- 2011-04-14 CN CN201510982692.9A patent/CN105560245A/zh active Pending
- 2011-04-14 CN CN2011800192025A patent/CN102844032A/zh active Pending
- 2011-04-14 SG SG2012073565A patent/SG184430A1/en unknown
- 2011-04-14 MX MX2012011938A patent/MX2012011938A/es not_active Application Discontinuation
- 2011-04-15 US US13/087,624 patent/US20110257192A1/en not_active Abandoned
-
2012
- 2012-10-09 IL IL222244A patent/IL222244A0/en unknown
- 2012-10-12 ZA ZA2012/07696A patent/ZA201207696B/en unknown